These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 36031998)
21. Recent insights into SARS-CoV-2 omicron variant. Silva SJRD; Kohl A; Pena L; Pardee K Rev Med Virol; 2023 Jan; 33(1):e2373. PubMed ID: 35662313 [TBL] [Abstract][Full Text] [Related]
22. COVID-19 pandemic dynamics in South Africa and epidemiological characteristics of three variants of concern (Beta, Delta, and Omicron). Yang W; Shaman J medRxiv; 2022 Jun; ():. PubMed ID: 34981071 [TBL] [Abstract][Full Text] [Related]
23. SARS-COV-2 Variants: Differences and Potential of Immune Evasion. Hirabara SM; Serdan TDA; Gorjao R; Masi LN; Pithon-Curi TC; Covas DT; Curi R; Durigon EL Front Cell Infect Microbiol; 2021; 11():781429. PubMed ID: 35118007 [TBL] [Abstract][Full Text] [Related]
24. Infectivity versus fatality of SARS-CoV-2 mutations and influenza. Xue L; Jing S; Zhang K; Milne R; Wang H Int J Infect Dis; 2022 Aug; 121():195-202. PubMed ID: 35584743 [TBL] [Abstract][Full Text] [Related]
25. Omicron: the highly mutational COVID-19 variant with immune escape. Khajotia R Pan Afr Med J; 2022; 41():84. PubMed ID: 35432693 [TBL] [Abstract][Full Text] [Related]
26. Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2. Parums DV Med Sci Monit; 2022 Feb; 28():e936199. PubMed ID: 35102132 [TBL] [Abstract][Full Text] [Related]
27. Twice evasions of Omicron variants explain the temporal patterns in six Asian and Oceanic countries. Chen B; Zhao Y; Jin Z; He D; Li H BMC Infect Dis; 2023 Jan; 23(1):25. PubMed ID: 36639649 [TBL] [Abstract][Full Text] [Related]
28. Simultaneous Screening of SARS-CoV-2 Omicron and Delta Variants Using High-Resolution Melting Analysis. Aoki A; Mori Y; Okamoto Y; Jinno H Biol Pharm Bull; 2022 Apr; 45(4):394-396. PubMed ID: 35067489 [TBL] [Abstract][Full Text] [Related]
29. Hotspots for SARS-CoV-2 Omicron variant spread: Lessons from New York City. Ramírez JD; Castañeda S; Ballesteros N; Muñoz M; Hernández M; Banu R; Shrestha P; Chen F; Shi H; ; van Bakel H; Simon V; Cordon-Cardo C; Sordillo EM; Paniz-Mondolfi AE J Med Virol; 2022 Jul; 94(7):2911-2914. PubMed ID: 35243662 [TBL] [Abstract][Full Text] [Related]
30. The Spread of SARS-CoV-2 Variant Omicron with a Doubling Time of 2.0-3.3 Days Can Be Explained by Immune Evasion. Grabowski F; Kochańczyk M; Lipniacki T Viruses; 2022 Jan; 14(2):. PubMed ID: 35215887 [TBL] [Abstract][Full Text] [Related]
31. Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants. Accorsi EK; Britton A; Fleming-Dutra KE; Smith ZR; Shang N; Derado G; Miller J; Schrag SJ; Verani JR JAMA; 2022 Feb; 327(7):639-651. PubMed ID: 35060999 [TBL] [Abstract][Full Text] [Related]
32. The immune evasion ability of Delta variant is comparable to that of Beta variant in South Africa. He D; Chen B; Zhao S; Stone L BMC Public Health; 2023 Mar; 23(1):511. PubMed ID: 36927400 [TBL] [Abstract][Full Text] [Related]
33. COVID-19 pandemic dynamics in India, the SARS-CoV-2 Delta variant, and implications for vaccination. Yang W; Shaman J medRxiv; 2021 Nov; ():. PubMed ID: 34845460 [TBL] [Abstract][Full Text] [Related]
34. Characteristics of infections with ancestral, Beta and Delta variants of SARS-CoV-2 in the PHIRST-C community cohort study, South Africa, 2020-2021. Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Gómez-Olivé FX; Dawood FS; Mkhencele T; ; Tempia S BMC Infect Dis; 2024 Mar; 24(1):336. PubMed ID: 38515050 [TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues. Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025 [TBL] [Abstract][Full Text] [Related]
37. Mathematical Modeling of SARS-CoV-2 Omicron Wave under Vaccination Effects. González-Parra G; Arenas AJ Computation (Basel); 2023 Feb; 11(2):. PubMed ID: 38957648 [TBL] [Abstract][Full Text] [Related]
38. Is Omicron really mild? - Comparative analysis of comorbidities and disease outcomes associated with SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants. Manchanda V; Mitra S; Rafique I; Sharma A; Dhakad MS; Saxena S; Kapoor S; Kumar S Indian J Med Microbiol; 2023; 45():100391. PubMed ID: 37573055 [TBL] [Abstract][Full Text] [Related]
39. Changing character and waning impact of COVID-19 at a tertiary centre in Cape Town, South Africa. Hermans LE; Booysen P; Boloko L; Adriaanse M; de Wet TJ; Lifson AR; Wadee N; Papavarnavas N; Marais G; Hsiao NY; Rosslee MJ; Symons G; Calligaro GL; Iranzadeh A; Wilkinson RJ; Ntusi NAB; Williamson C; Davies MA; Meintjes G; Wasserman S S Afr J Infect Dis; 2023; 38(1):550. PubMed ID: 38223432 [TBL] [Abstract][Full Text] [Related]
40. Characterisation of Omicron Variant during COVID-19 Pandemic and the Impact of Vaccination, Transmission Rate, Mortality, and Reinfection in South Africa, Germany, and Brazil. Ribeiro Xavier C; Sachetto Oliveira R; da Fonseca Vieira V; Lobosco M; Weber Dos Santos R BioTech (Basel); 2022 Apr; 11(2):. PubMed ID: 35822785 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]